M R Parkhurst - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M R Parkhurst

Showing results (11-20 of 14) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 14 results.

Cancer Research|January 8, 2000

MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyteM I Nishimura, D Avichezer, M C Custer, et al.

The Journal of Experimental Medicine|July 22, 1998

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.

Cancer Research|June 11, 1999

Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.

Nature Medicine|March 21, 1998

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.

Pageof 2

Search research articles

Showing results (11-20 of 14) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 14 results.

Cancer Research|January 8, 2000

MHC class I-restricted recognition of a melanoma antigen by a human CD4+ tumor infiltrating lymphocyteM I Nishimura, D Avichezer, M C Custer, et al.

The Journal of Experimental Medicine|July 22, 1998

gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.

Cancer Research|June 11, 1999

Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.

Nature Medicine|March 21, 1998

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanomaS A Rosenberg, J C Yang, D J Schwartzentruber, et al.

Pageof 2